Fractional Flow Reserve Market

Global Fractional Flow Reserve Market Size (2023 to 2028)

The global fractional flow reserve market is poised to register a CAGR of 16.0% during the projected period and the global market size is expected to grow from USD 813 million in 2023 to USD 1980 million by 2028.

Fractional flow reserve (FFR) is a minimally invasive procedure to figure out the narrowing condition (stenosis) in the coronary arteries. Fractional flow reserve is carried out before angioplasty to determine the stent to be inserted in the coronary artery. The fractional flow reserve helps healthcare professionals determine whether to go for therapeutic treatment or revascularization. The diseases like (CAD) Stable coronary artery disease and (ACS) Acute Coronary Syndrome can be diagnosed accurately and easily.

MARKET DRIVERS:

The number of people suffering from coronary artery disease (CAD) is increasing all over the world. Millions of patients are diagnosed with CAD every year. Obesity and aging are the two biggest reasons for the occurrence of CAD disorders, which is expected to boost the growth of the fractional flow reserve (FFR) market. As the FFR helps to assess the condition of the CAD and thus, further decisions regarding the treatment can be made. New FFR catheters that are smaller and easier to use as compared to traditional catheters have entered the fractional flow reserve market, and advanced software has been designed for the convenience of performing the tests. Cardiac catheterization is a process preferred over traditional open-heart surgery as the recovery time associated with the catheterization process is far less as compared to open-heart surgery. As cardiac catheterization is a minimally invasive process, the usage of this procedure will increase in the coming future.

An increasing number of patients with CAD, advanced technologies in the fractional flow reserve market, and the rising popularity of minimally invasive procedures in the form of cardiac catheterization are other major factors propelling the growth of the fractional flow reserve market growth.

MARKET RESTRAINTS:

The devices used for fractional flow reserve procedures are expensive, which ultimately increases the cost of treatment or procedures and is a key factor hampering the growth of the global market. As the prices are way too high compared to other procedures like angiography and angioplasty, Patients prefer these procedures over fractional flow reserve. This limits the expansion of the fractional flow reserve market to a limited number of people and in a limited region. This restricts the growth of the fractional flow reserve market growth. Many cardiologists do not shift or adopt the reserve system due to the comfort of using the angiography and angioplasty methods and the visual assessment of the severity of stenosis. These personal reasons limit the expansion of the fractional flow reserve market share. There is still a lack of awareness about the use of fractional flow result systems among healthcare professionals and patients across the world, especially in underdeveloped and developing economies, which limits the growth of the fractional flow reserve market share in many of the unpenetrated regions. Therefore, high prices of fractional floor reserve procedures, insufficient adoption by experts, and lack of awareness and adoption among healthcare providers and patients are the major factors that limit the growth of the fractional flow reserve market.

Impact of COVID-19 on the fractional flow reserve market:

The COVID-19 pandemic had a negative impact on the fractional flow reserve market. The patients who tested positive for the COVID-19 virus were a priority for the healthcare sector as well as the hospitals. Due to this, the number of patients on whom cardiac catheterization was performed decreased significantly. The cases which fell in the nonemergency category were postponed or canceled until further notice. Even if cardiac catheterization is carried out on a patient, the time and resources spent on monitoring the patient are way too much and can be used for the treatment of COVID-19 patients.

The COVID-19 pandemic has disrupted the global supply chain from top to bottom completely. Due to this, the supply of essential raw materials and other components to produce fractional flow reserve, could not be done to the manufacturers. Also, the finished FFR systems could not be delivered to the end users. Although the fractional flow reserve market experienced a decline in market growth during the COVID-19 outbreak, in the post-pandemic period, the fractional flow reserve market is gaining back market growth rapidly as the surgeries that had been canceled or postponed during the pandemic are now being carried out. Also, the technological advancements happening in the field have helped the fractional flow reserve market share to grow rapidly.

REPORT COVERAGE:

The research report on the global fractional flow reserve market segmentation has been segmented based on application, product, and region.

Fractional Flow Reserve Market- Based on Application:

• Multivessel CAD
• Single vessel CAD

The multi vessel CAD segment is ruling the fractional flow reserve market with a market share of 62%. Risk factors for multi-vessel CADR hypertension, diabetes and obesity are increasing day by day all over the world and thus, vessel CAD is also on the rise. The aging population is prone to be affected with multivessel CAD and thus, the prevalence of the disease is more common in countries like the United States, where the aged population is increasing rapidly as compared to the young workforce.

This single vessels CAD segment is growing at a much lower growth rate as compared to multi-vessels CAD, where the single-vessel CAD segment accounts for around 38% of the fractional flow reserve market share. Angiography is mostly preferred for single-vessel CAD as the single-vessel CAD segment is less severe when compared to multi-vessel CAD. Still, fractional flow reserve is a more accurate and reliable method thus, its usage has been increasing for both single vessel as well as multi vessel CAD.

Fractional Flow Reserve Market- Based on Product:

• Monitoring systems
• Guidewires

The Guidewire segment is leading the fractional flow reserve market with a market share of 58%. Extensive usage of guide wires has been noticed all over the world in diagnostic cardiovascular procedures. The guidewires is a tried and tested technology and thus is preferred by most healthcare professionals over the world.

The monitoring systems account for 42% of the fractional flow reserve market share. The system is still in the evolving stage and thus, the growth rate is expected to be lower as compared to guide wires. Remote monitoring can be done using this system and the results that we get are more reliable and accurate.

Fractional Flow Reserve Market- Based on Region:

• Asia Pacific
• North America
• Europe
• Latin America
• Middle East & Africa

North America is leading the (FFR) fractional flower reserve market with a market share of more than 41%. The government policies in the North American region favor the growth of the fractional flow reserve market. The United States is the biggest market for fraction flow reserves in the North American region due to the rising number of patients suffering from cardiovascular diseases. Also, the U.S. has the highest aged population.

Europe for the second position in the fractional shore reserve market with 27% of the market share. The well-developed healthcare infrastructure in most European countries is the main reason for the growth of the fractional flow reserve market in Europe. The government policies that are beneficial for patients, like cost reimbursement for treatment, help the growth of the fractional flow reserve market share.

Asia Pacific region stands at the third spot in the fractional flow reserve market with 22% of the market share. The increasing demand for minimally invasive surgeries in the region is driving the fractional flow reserve market share toward growth. Also, the spending capacity of the patients in the region is rising slowly. Countries like India, Australia, South Korea, and China are the biggest markets for fractional flow is market in the Asia-Pacific region.

Latin America accounts for 8% of the fractional flow reserve market share. Countries like Mexico, Argentina, and Brazil are the biggest fractional flow reserve markets in the Latin American region. The poorly developed healthcare infrastructure in the region restricts the growth of national flow, resulting in market share.

Middle Eastern Africa region holds the lowest market share in the fractional flow reserve market over the world, with only two percent of the total market share. The biggest fractional flow reserve market in the African region is South Africa.

KEY MARKET PLAYERS:

The prominent key players in the fractional flow reserve market are HeartFlow Inc, CathWorks, Abbott, Boston Scientific, and Pie Medical Imaging led the fractional flow reserve market globally.

RECENT MARKET DEVELOPMENTS:

• In March 2019, US FDA approved Abbott’s RFR intravascular diagnostic test which is a new type of FFR.
• In January 2019, Opsens got CE certification for its Diastolic pressure algorithm.